Following the recent news that Royal Philips has launched its Avalon CL Fetal and Maternal Pod and Patch obstetrics monitoring solution for high-risk expectant mothers;

Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view:

“The lockdown measures in place across the globe have created the perfect scenario for rapid adoption of remote monitoring technologies. Philip’s new solution is part of a growing remote patient monitoring market, one which GlobalData expects to grow by 20% from 2019 to a size of $645 million dollars by 2025.

“The introduction of this product, along with Philips other recent offerings in the remote patient monitoring space such as a wearable biosensor for hospitalized COVID-19 patients, puts Philips in a strong position to be a market leader.

“The remote patient monitoring market has grown as the ongoing COVID-19 pandemic has forced healthcare professionals to seek out alternative methods of treatment and monitoring away from hospitals or clinics whenever possible as they attempt to minimize potential patient exposure to the virus. Incumbents such as Philips or Medtronic and disruptors including Google are looking to capitalize on this opportunity by introducing new hardware and software remote monitoring solutions in hopes of growing their market share.”